← The Wire
CAMPNasdaq
Camp4 Therapeutics Corp
Pharmaceutical Preparations · DE · CIK 1736730
Camp4 Therapeutics develops RNA-targeting therapeutics to upregulate gene expression and restore protein levels for genetic diseases
red 8-K · 90d
$218M
Market cap
$4.44
Last close
+5.7%
1D
+5.7%
5D
157K
Volume
Price · last 39 sessions+15.0%
May 4L $3.86 · H $4.56Jun 29
43
Total filings
Jun 12, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteJun 12, 20268-KReg FD DisclosureMay 14, 202610-Q10-QMay 7, 20268-KResults of OperationsMay 7, 2026DEFA14ADEFA14AApr 23, 2026DEF 14ADEF 14AApr 23, 20268-KExecutive ChangeMar 24, 2026SC 13D/ASC 13D/AMar 11, 202610-K10-KMar 5, 20268-KAcquisition / Disposition · Reg FD DisclosureMar 5, 20268-KReg FD DisclosureJan 9, 20268-KMaterial Agreement · Agreement TerminatedDec 23, 2025SC 13D/ASC 13D/ADec 23, 20258-KMaterial AgreementDec 18, 2025424B5424B5Dec 18, 20258-KMaterial Agreement · Reg FD DisclosureDec 18, 2025424B5424B5Dec 1, 202510-Q10-QNov 6, 20258-KResults of OperationsNov 6, 20258-KReg FD DisclosureOct 1, 20258-KExecutive Change · Material AgreementSep 10, 202510-Q10-QAug 14, 20258-KResults of OperationsAug 14, 20258-KShareholder VoteJun 13, 20258-KReg FD DisclosureMay 16, 202510-Q10-QMay 13, 20258-KResults of OperationsMay 13, 2025DEFA14ADEFA14AApr 30, 2025DEF 14ADEF 14AApr 30, 202510-K10-KMar 27, 20258-KResults of OperationsMar 27, 20258-KExecutive ChangeMar 18, 20258-KReg FD Disclosure · Company UpdateJan 7, 202510-Q10-QNov 21, 20248-KResults of OperationsNov 21, 2024SC 13GSC 13GOct 22, 2024SC 13DSC 13DOct 22, 2024SC 13GSC 13GOct 22, 2024SC 13DSC 13DOct 22, 2024SC 13DSC 13DOct 22, 20248-KBylaw AmendmentOct 15, 2024424B4424B4Oct 11, 2024S-1/AS-1/AOct 7, 2024S-1/AS-1/ASep 26, 2024S-1S-1Sep 20, 2024
Similar companies
Comparable business profile · signals at a glance